Friday, 25 September 2015

Viagra patent expires in China – Drug makers scramble to release cheap generics


viagra patentThe quality of these new products may be open to question, but the recent expiry of the Chinese patent for erectile dysfunction (ED) drug Viagra has led to a rush of pharmaceutical companies applying to make their own cheaper generic version of Pfizer’s hugely popular anti-impotence treatment for release in China.
It was recently disclosed that the Viagra patent had expired in China on May 12, almost a year after the UK patent had similarly ended for the ‘little blue pill’, and something which led to Medical Specialists™ Pharmacy offering fantastic bargains on UK-produced inexpensive generic versions of Viagra.
For example, buy viagra, buy cialis, buy vitaros from Medical Specialists’™ extensive ED medication range, and patients have the option to buy sildenafil at rock bottom prices, resulting in a surge in demand.
It is believed that over a dozen drug makers in China have applied to the China Food and Drug Administration (CFDA) to try and have their own generic versions of Viagra approved for release, with sources claiming many of these actually first began the process around two years ago.
The stigma around erectile dysfunction has been slowly eroded in the 16 years since Pfizer’s Viagra burst onto the scene and more men are now willing to come forward to trusted sources like Medical Specialists™ and seek help. Finally, ED is widely accepted as a genuine health problem that can lead to catastrophic consequences, such as loss of self-esteem, anxiety and even relationship difficulties.
In China alone, the market for ED drugs is now worth an estimated 60 billion Yuan (roughly £5.65 billion) each year.
Also available in China are two of the other most commonly prescribed ED medications – Eli Lilly’s Cialis and Bayer’s Levitra, but Viagra has proved to be the most popular, comprising of over half (58%) of the total sales for ED drugs across 27 major cities in the country last year.
Pfizer China have confirmed they have no immediate plans to release a low-cost version of Viagra regardless of the increase in competition they face.
“For any research-based drug makers, the expiration of a drug patent is a common happening and does not means the end of the world for a product,” Xi Qing, communications director at Pfizer China, said, clearly confident about Viagra keeping a good share of the market in the country.
However, In China about 90% of drugs are generic and it is a market expected to reach 500 billion Yuan by next year. Back in 2011 Pfizer also lost the patent for its money making blockbuster drug Lipitor, which is a commonly prescribed medication for the treatment of high cholesterol.
Lipitor (atorvastatin) brought in staggering revenues for Pfizer that totalled billions of dollars, but that all changed when the patent expired and sales of the branded drug took a serious plunge, and a similar scenario could now happen for Viagra in China.

www.medical-specialists.co.uk

European alcohol, smoking and obesity rates are ‘alarming’ says WHO


cigaretteThe United States is often branded the fattest country in the world (technically true depending on which statistics are used), however Europe is doing its best to take over this unwanted mantle from America, with “alarming” rates of drinking, eating and smoking found throughout Europe in a new report conducted by the World Health Organization (WHO).
In the United States, a staggering 78 million people, or 33% of the adult population, are classified as obese, whilst 74.1% of the people aged 15 and over are either overweight or obese (i.e. with a body mass index (BMI) of 25 or above).
However, health officials have now stressed that Europe has the world’s highest rates of drinking and smoking, with more than half of people now fat, which could ultimately lead to a whole number of serious health problems such as asthma, cancer, heart disease, osteoarthritis and stroke.
In what is the first study of its kind for three years, the European Health Report 2015 looked at 39 countries including European Union member states, in addition to former Soviet republics, to see if the WHO’s ‘Health 2020’ targets are being met.
It was discovered that the average life expectancy for men and women can drastically vary, ranging from 71 years of age in Belarus, Moldova and Russia, to 82 in France, Italy and Spain, according to figures from 2011. Overall, life expectancy for Europeans has risen from an average of 73.2 years back in 1990, to 76.8 years by 2011.
“There is a very real risk that these gains will be lost if smoking and alcohol consumption continue at the current rate. This is especially relevant to young people, who may not live as long as their grandparents”, said Zsuzsanna Jakab, WHO’s regional director, speaking to the Guardian.
WHO noted that many European countries seemed to have lower risk factors for premature death, the rates of obesity, tobacco use and alcohol consumption “remain alarmingly high”. The United Nations health agency calculated that in the previous four years, a growing number of Europeans are now classed as either overweight or obese, with 58.6% of Europeans overweight, and 23% suffering from obesity.
The report states that obesity is “one of the greatest public health challenges of the 21st century”, which “drastically increases a person’s risk of developing several [diseases], including cardiovascular diseases, cancer and diabetes mellitus”.
There is also a great deal of concern about Europe’s drinking and smoking habits. Although between 2005 and 2010, total alcohol consumption lowered by 10% in Europe, the continent still has the highest drinking rates across the globe.
Europe has the world’s highest prevalence of alcohol dependence (4%) according to the report, as well as the highest prevalence of alcohol-use disorders (7%). It is estimated that an average of 11 litres of pure alcohol are consumed per person every year, whilst around 30% of Europe uses tobacco.
“Europeans live long lives and healthy lives. We are the longest living region in the world,” said Claudia Stein, a senior WHO director for Europe.
She continued: “The differences in health status between European countries are inexplicably wide.
Stein warned that this could have the most serious impact on younger people, since their lives may be shortened unless action is taken to bring down consumption levels of tobacco, alcohol and calories.
“If rates of smoking and alcohol consumption and obesity do not decline we may risk the gains in life expectancy we have seen — which may mean that the next generation may lead shorter lives than that we do.”

www.medical-specialists.co.uk

Thursday, 24 September 2015

Male impotence drug Viagra makes it hard for Malaria to spread


viagraThe hugely popular erectile dysfunction medication Viagra (sildenafil citrate) has been taken by men all around the world for over 15 years to help stiffen erections for sex, and it seems this very stiffening prowess has been found to be the key element in aiding a decreased risk in the transmission of the mosquito-borne malaria parasite Plasmodium from humans to mosquitoes. In turn, this would then prevent a further passing of the virus to other people.
The findings have been laid bare in a study conducted by the London School of Hygiene and Tropical Medicine in collaboration with the CNRS, INSERM, Université Paris Descartes at the Institut Cochin and the Institut Pasteur.
How the malaria transmission can be blocked through then use of Viagra was explained by study co-author David Baker, Professor of Malaria Parasite Biology at the London School of Hygiene and Tropical Medicine.
He said: “In this new study we show that Viagra, a drug shown to be safe in humans, can make the sexual forms of the malaria parasite stiff.
“This causes them to be inactivated in the spleen and so prevents transmission of the sexual malaria parasites to mosquitoes. This is an interesting proof of concept which gives us hope that new drugs could be developed that specifically target the malaria parasite phosphodiesterase enzymes and block malaria transmission,” he added.
Plasmodium falciparum is one of the parasites that triggers the infectious, and sometimes deadly disease malaria. This parasite isn’t always easy to treat, with experts believing the single celled organism is evolving to become more resistant to the most commonly prescribed antimalarials. It is this reason why researchers continually look for other ways to fight the disease.
The parasite develops in a person’s red blood cells, which are emitted by bone marrow into the blood stream. Should a mosquito bite somebody that is already infected, it will extract some of the parasites within the blood and there is a risk that the mosquito could then infect another person by biting them.
As the blood circulates, stiff, old or abnormal blood cells are taken in by the spleen, with the healthier normal cells left to travel around. With the Viagra though, the infected red blood cells are taken in by the spleen – meaning they are not available for mosquitoes to get after biting someone. Sildenafil maintains a signalling pathway within the red blood cells, which results in the molecule cAAMP becoming more concentrated and the cells stiffening.
So far, tests have only been conducted using test tubes and there will need to be carried out with animals. If those show signs of success the next trials will need to involve humans before any medication can be approved for the use of malaria prevention.

www.medical-specialists.co.uk

Female Viagra drug Flibanserin on the cusp of FDA approval


female viagraSince Pfizer’s male impotence wonder drug Viagra first burst onto the scene an incredible 17 years ago, it was subsequently joined by Eli Lily’s Cialis and Bayer’s Levitra by 2003.
Over the next 12 years the industry has witnessed variations on these such as the lower-strength Cialis Daily tablets for the more ‘active’ male and Levitra orodispersible tablets – especially suitable for men who aren’t comfortable with swallowing pills, wanting to take it with some discretion and without the requirement of a glass of water.
Men also have the options of the newer erectile dysfunction treatment Spedra (Avanafil) or Vitaros cream – ideal for men that have not experienced success with the aforementioned PDE5 inhibitor tablets or cannot take PDE5s for medical reasons.
If all that wasn’t enough choice, men suffering with premature ejaculation have over-the-counter premature ejaculation treatments such as Stud 100 Spray, condoms containing benzocaine like Durex Performa (to prolong climax), whilst there is also prescription medication such as Priligy, which is taken orally and works to prolong a man’s sexual performance by an average of 200% to 300%.
Simply put, men are spoilt for choice when it comes to finding the right treatment option for sexual dysfunction, whether this be for persistent impotence or premature ejaculation problems.
So, what is there for women? If Medical Specialists® Pharmacy were to quiz our thousands of patients to come up with the name of an existing female sexual dysfunction treatment, we’d be surprised if anyone could muster a reply.
In early 2014 Medical Specialists® reported how British pharmaceutical company ORLIBID were developing a drug tentatively titled ‘ORL101’, aimed at boosting a woman’s sex drive, however no further information has been released about ORL101 since then.
However, Medical Specialists® are delighted to announce that a new pill to boost a woman’s libido could be one step closer after US experts gave its endorsement. This will be fantastic news for those that have fought for women’s sex drives to get a similar medical attention to deal put into it as the male treatments.
A panel of Food and Drug Administration (FDA) advisers decided to vote 18-6 in favour of recommending flibanserin, a daily pill nicknamed the ‘female Viagra’ and manufactured by Sprout Pharmaceuticals, who picked up the drug back in 2011 after its initial developer, Boehringer Ingelheim, decided to drop it.
The vote came following a testimony from various women who vigorously persuaded the agency to approve the drug and told of their fear of never being able to have sex again. The final judgement of course will have to come from the FDA themselves, with a verdict on suitability for public use due later this year.
Coincidentally, flibanserin, just like the discovery of Viagra, was an unintended find. The drug was firstly developed with the intention of treating depression, but wasn’t as effective for this purpose as expected.
Many of the 11,000 women involved in the trials did note that they were experiencing some rather unexpected side effects from the flibanserin. Increased sexual interest and overall, more satisfying sexual experiences than previous, were being commonly reported.
North Carolina drug maker Sprout Pharmaceuticals, have claimed that their clinical trials have demonstrated that women have experienced a 37% rise in sexual desire in comparison to a placebo. The women reported an average of between 0.5 and one more sexually satisfying events each month, compared to those women taking a placebo. In addition, they had higher scores on questionnaires on desire and scored lower on questions about stress.
The drug – which changes brain chemistry as opposed to Viagra increasing blood flow – isn’t without a chequered history though, with the FDA twice rejecting the drug since 2010, arguing flibanserin’s benefits did not outweigh the risks, which can include low blood pressure and fainting spells.
However, Susan Scanlan, chairwoman of Even The Score, hit back and noted that Viagra can have varying side effects, arguing that the FDA hasn’t approved flibanserin because of their discomfort with women taking control over their sexuality. “The implication is that men can be trusted to make a rational decision of risk versus reward and women can’t,” she said.
The FDA has highlighted female sexual dysfunction as one of 20 priority areas of unmet medical need, and is obviously a major and genuine health problem that needs to be addressed.
Keep checking the Medical Specialists® NHS Pharmacy website for further updates about flibanserin or other female sexual dysfunction products that may become available in the future, and we already have an extension range of male impotence and premature ejaculation treatments, some of which were mentioned earlier.

www.medical-specialists.co.uk 

UK seizure of £15.8 million worth of counterfeit and unlicensed medicines and devices


counterfeit drugsToday (18 June) The Medicines and Healthcare products Regulatory Agency (MHRA) announced that a staggering haul of fake and unlicensed medicines and devices have been seized across Britain as part of an ongoing global operation.
The huge haul totals around £15.8 million and the seizures represent the biggest to be recorded in the UK. The types of drugs to be counterfeited include massive amounts of the usual suspects that are often imitated; erectile dysfunction and slimming pills, in addition to anaemia and narcolepsy tablets. Fake condoms and unlicensed foreign medicines were also seized.
The MHRA instigated the ‘Operation Pangea VIII’ initiative with INTERPOL, carrying out a series of worldwide drug raids during the week of 9 and 16 June, leading to 156 arrests in numerous different countries.
In news that comes as a delight to Medical Specialists®, after ourselves publishing several articles on how to spot an illegal website/fake ‘pharmacy’, Operation Pangea VIII also involved the shutting down of illicit websites that were duping customers with falsified, counterfeit and unlicensed medicines.  These websites were hit with a closure or suspension by removal of their domain name or payment facility.
Closer to home the MHRA enforcement officers joined forces with local police to conduct raids on known suspect addresses across Britain, addresses connected to the illegal online supply of potentially deadly medicines.
This led to a seizure of nearly 6.2 million doses of falsified, counterfeit and unlicensed medicines in the UK, 15,000 of which were found to be medical devices that had an estimated total value of £15.8 million. Thanks to UK operations, 1,380 websites were shut down, 339 being domestic sites.
MHRA Head of Enforcement, Alastair Jeffrey, said: “Operation Pangea is the global response to internet-facilitated medicines and devices crime. As a result of our intelligence-led enforcement operations we have seized £15.8 million worth of counterfeit and unlicensed medicines and 15,000 devices in the UK alone – which is almost twice as much as we recorded last year, and clear evidence that this is a growing concern that has to be taken seriously.
“Criminals involved in the illegal supply of medical products through the internet aren’t interested in your health – they are interested in your money and are able to get this by selling you a potentially dangerous product, or by stealing your bank details. To protect your health, visit your GP, get a correct diagnosis and buy medicines from a legitimate high street or registered pharmacy which can trade online.”
Most of the products seized in UK were imported from overseas, with India, China, Hong Kong and Singapore being the main countries in question.
With crooks always looking at new means to target potential customers, this has resulted in the MHRA investigating YouTube accounts and videos – leading to over 320 videos being taken off the site.
On a more global scale, regulators and custom officials analysed almost 150,000 packages and seized in excess of 20.7 million doses of unlicensed and counterfeit medicines, worth about £51.6 million.
Alex Lawther, from Border Force’s postal command, added: “Border Force regularly detects and seizes illegal and restricted products imported through the postal system including fake and unlicensed medicines. Our involvement in this operation with the MHRA demonstrates our commitment to combat this form of smuggling. Our message to the public is simple – don’t buy anything online unless you are certain it comes from a legitimate source.”

www.medical-specialists.co.uk

Erectile Dysfunction prescriptions soar 25% in a year


coupleJust a week ago Medical Specialists® Pharmacy dramatically lowered the prices on ALL erectile dysfunction treatments, such as Viagra, generic sildenafil, Cialis, etc., and the response in the subsequent seven days has shocked even those at Medical Specialists®.
With this huge price crash, thousands of male patients from all over the UK suffering with impotence – and indeed other countries around the globe – have been using the online consultation service to submit orders for various erectile dysfunction treatments. To give an example of the price drop, 4 x Viagra 100mg tablets were previously priced at £55.95 (Inc. delivery to mainland UK), but are now priced at just £34.95.
Perhaps many have suffered in silence for too long and finally decided to seek help from Medical Specialists®, or were simply deterred by the cost of the medications, either way it seems our staggering cost reduction to patients has resulted in a soar in requests for erectile dysfunction treatments.
It is not just at Medical Specialists® though where requests for male impotence medications are coming in thick and fast, with new figures showing that prescriptions for erectile dysfunction drugs such as Viagra soaring by over 25% within a year in the UK, as costs reduced by 85.9% with the availability of generic versions from 2013.
According to statistics from the Health and Social Care Information Centre (HSCIC), last year there was found to be 1.7 million prescriptions dispensed for sildenafil (often sold as the branded Viagra), but is also obtainable under other trade names.  The HSCIC report analyses prescriptions dispensed by community pharmacists, dispensing doctors and in GP practices.
In comparison, there were 1.4 million prescriptions of sildenafil dispensed during 2013, and just one million back in 2004. For purely sildenafil alone, it was found that prescriptions increased by 21% during the previous year.
However, drugs for other conditions have seen a large increase in prescriptions too, with HSCIC figures showing that antidepressants, which includes medications for depressive illness, generalised anxiety disorder (GAD), obsessive-compulsive disorder, and panic attacks, increased by 7.2%, with 57.1 million dispensed last year, compared to 53.3 million in 2013. That means the number of dispensed prescriptions for antidepressants has almost doubled from the 29 million dispensed in 2004.
Other HSCIC stats show that in excess of 1.06 billion drugs were prescribed across England in 2014, a rise of 3.3% on the number prescribed during 2013 and an incredible rise of 55.2% on 2004.
Another finding was that the overall net ingredient cost of prescriptions in 2014 stood at £8.85 billion, representing a 2.6% rise of 2013 and 9.6% increase over the previous 10 years.
For the eighth successive year, the most amount of money went on diabetes drugs, with a 7% increase – rising by £55.3 million from 2013 to 2014, to reach £849.1 million.
Popular cholesterol drug Atorvastatin, a treatment that helps to cut the risk of heart attacks and strokes, was discovered to have the biggest rise in the number of items dispensed, with a four million rise since 2013.

www.medical-specialists.co.uk

Erectile Dysfunction linked to undiagnosed type 2 diabetes


coupleIt can be a daunting prospect for people to pluck up the courage to go and speak to their doctor about problems related to sex, especially maybe if said doctor treats the whole family or is regarded as a friend.
This explains somewhat why Medical Specialists® Pharmacy have a patient base spanning tens of thousands; people that have come to them primarily to use the online consultation service for erectile dysfunction treatments, or for the treatment of premature ejaculation. The benefit with this service is the whole process can be done online, confidentially, efficiently, securely, without a face-to-face visit to your doctor, as everything is processed in-house at Medical Specialists® and no information passed to third-parties.
However, men suffering with problems in the bedroom should take these problems more serious, as they could be a predictor for other undiagnosed conditions, such as diabetes. Gum disease and erectile dysfunction has already been linked in previous studies.
In addition, studies have also demonstrated that erectile dysfunction could be an early warning of cardiovascular disease. However, researchers have now shown that a possibly link exists between erectile dysfunction and undiagnosed hypertension, hypercholesterolemia, as well as undiagnosed type 2 diabetes.
This according to the results from a cross-sectional survey which is featured in the July/August issue of the Annals of Family Medicine, with researchers involved in the study arguing men – especially those in middle-age – with impotence problems should be able to receive diabetes screening.
The Study’s lead researcher Dr. Sean Skeldon, from the University of Toronto in Canada, says the risks were higher in middle-aged men aged 40 to 59 years old. He commented: “The probability of having undiagnosed diabetes increased from one in 50 in men without erectile dysfunction, to one in 10 in men with erectile dysfunction.”
Results were attained by collating the data from more than 4,500 men from the United States; all over the age of 20 and participating in the National Health and Nutrition Examination Survey from 2001 and 2004. The study was conducted with the aim of trying to find if associations existed between male impotence and blood pressure, cholesterol, in addition to blood sugar. Interestingly, the researchers couldn’t seem to find a link with problems achieving or sustaining an erection to undiagnosed high blood pressure or high cholesterol.
However, the findings showed that 11.5% of the men with undiagnosed diabetes had also stated they suffered with impotence problems, with an even bigger proportion for men between the ages of 40 to 59 years old – 19% showing unusually high blood sugar.
All men– particular those middle-aged– have some degree of risk of type 2 diabetes even without a diagnosis and the researchers suggest that doctors should get not only screenings, but also the sexual histories of middle-aged men.
Type 2 diabetes has been strongly linked with both genetics and ethnicity, but an incredibly large percentage of cases of type 2 diabetes are caused by poor diet that leads to being overweight or due to obesity. With early enough lifestyle changes such as improving your diet, regular exercise and weight loss, it may just be enough to slow down or even prevent the onset of type 2 diabetes.

www.medical-specialists.co.uk